`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`MEDTRONIC, INC., AND MEDTRONIC VASCULAR, INC.
`Petitioners,
`
`v.
`
`TELEFLEX INNOVATIONS S.A.R.L.
`Patent Owner.
`
`
`
`
`Case IPR2020-00131
`U.S. Patent No. RE45,380
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER’S RESPONSE TO PETITIONERS’
`REQUEST FOR REHEARING
`
`
`
`
`Patent Owner Teleflex files this 5-page response to Petitioner Medtronic’s
`
`Request for Rehearing pursuant to authorization received from the Board during a
`
`telephone call on July 30, 2020. On June 26, 2020, the Board issued a Decision
`
`denying institution of inter partes review for claims 25-39 of U.S. Patent No.
`
`RE45,380 (“the ʼ380 patent”). Paper 20 at 5. The Board’s Consolidated Trial
`
`Practice Guide specifies that the Board has a general policy of one petition per
`
`patent. Medtronic sought to bring not just two or three petitions against the ’380
`
`patent, but four. The Board determined that Medtronic failed to justify the fourth
`
`petition challenging the ʼ380 patent and accordingly exercised its discretion under
`
`35 U.S.C. § 314 to deny the petition. Id.
`
`As the Board correctly recognized, Medtronic’s 2020-00129 IPR petition
`
`already contained two challenges to claims 25-39 of the ’380 patent—one based on
`
`the Itou reference, and a second based on the Ressemann reference. Paper 20 at 5.
`
`Medtronic’s justification for its 2020-00131 IPR petition challenging the same
`
`claims a third time—that it needed a “back-up” challenge in the event Itou was not
`
`prior art—was completely unsupported. Medtronic’s -00129 IPR petition already
`
`contained a “back-up” challenge to claims 25-39: in the event Itou was found not
`
`to be prior art, “the petition in the -00129 IPR would still contain grounds
`
`addressing every challenged claim based on a primary reference (Ressemann) that
`
`Patent Owner has not attempted to swear behind.” Paper 20 at 5. The -00131 IPR
`
`1
`
`
`
`petition, based on the Kontos reference, was just a third, unnecessary challenge to
`
`that same set of claims.
`
`With its Request for Rehearing, Medtronic asks again for this third bite at
`
`the apple, providing new reasons it purportedly needs a third bite. However, it fails
`
`to point to anything that the Board misapprehended or overlooked in its decision
`
`not to institute the -00131 IPR. Thus, Medtronic has failed to carry its burden to
`
`show that the Board’s non-institution decision should be modified. See 37 C.F.R.
`
`§42.71(d). What’s more, even Medtronic’s new arguments are unsupported.
`
`Medtronic’s Request for Rehearing should be denied.
`
`I.
`
`Argument
`
`A. Medtronic’s Request for Rehearing Should Be Denied Because it
`Improperly Raises New Arguments
`A party requesting rehearing of a Board decision has the burden to show that
`
`the decision should be modified. 37 C.F.R. § 42.71(d). The rehearing request
`
`must “specifically identify all matters the party believes the Board misapprehended
`
`or overlooked, and the place where each matter was previously addressed in a
`
`motion, an opposition, or a reply.” Id.
`
`Medtronic already had an opportunity to explain why the -00131 petition
`
`was necessary in view of the three other petitions it filed challenging the ʼ380
`
`patent. Paper 2. Medtronic used that opportunity to explain that two petitions per
`
`claim were necessary because of the priority dispute related to Itou. Paper 2 at 1-3.
`
`2
`
`
`
`The Board considered this argument and found that the -00129 IPR provided
`
`sufficient “back-up” for the Itou-based grounds. Paper 20 at 5. The Board’s
`
`decision was correct, and Medtronic does not now dispute that.
`
`Instead, Medtronic’s rehearing request is based on new—though equally
`
`unsupported—reasons as to why it purportedly needs this third-bite petition.
`
`Medtronic now argues, for the first time, that non-institution of the -00131 IPR will
`
`result in conflicting patentability findings and that review will not burden the
`
`Board or the parties because the challenged claims are “substantially similar” to
`
`the other instituted claims. See generally Paper 21 at 2-8. A rehearing request is
`
`not the proper place to raise these new arguments, and Medtronic’s request should
`
`be denied.
`
`B. Claims 32 and 33 of the ʼ380 Patent Are Distinct from the Claims
`Challenged in other Instituted Petitions
`
`
`Even if the Board is inclined to engage Medtronic’s new arguments on the
`
`substance, the new arguments are unsupported. Medtronic’s request for rehearing
`
`is premised on the position that claims 32 and 33 are similar to the already-
`
`instituted “one-French” claims 8 and 17 in the -00127 IPR and 8 and 18 in the -
`
`00130 IPR. According to Medtronic, this presents the risk of inconsistent
`
`outcomes. Paper 21 at 3-4. But claims 32 and 33 of the ʼ380 patent are different
`
`from these claims. For example, unlike the “one-French” claims of the -00127 and
`
`-00130 IPRs, claims 32-33 (by virtue of depending from claim 25) require a guide
`
`3
`
`
`
`extension catheter with a means for receiving an interventional device “from an
`
`intermediate or distal portion” of the standard guide catheter. Ex. 1801 at cl. 25.
`
`Claims 32-33 (by virtue of depending from claim 25) are also means-plus-function
`
`claims, unlike the “one-French” claims challenged by the -00127 and -00130 IPRs.
`
`Ex. 1801 at 13:43-14:64. The analysis for these means-plus-function claims is
`
`distinct from the analysis for the non-means-plus-function claims in the other two
`
`IPRs.
`
`For the same reasons as the Board already found, instituting review of
`
`claims 25-39 of the ʼ380 patent on the bases set forth in the -00131 IPR petition
`
`will most certainly “place a substantial and unnecessary burden on the Board and
`
`the patent owner” and “raise fairness, timing, and efficiency concerns.” Trial
`
`Practice Guide at 59. The law, facts, and analysis that would bear on the claims at
`
`issue in the -00131 IPR is different from that of the other IPRs Medtronic
`
`identified.
`
`C. Medtronic Made the Strategic Decision to Challenge the Claim 25
`Set on Two “Back-Up” Grounds and It Should Not Get a Third
`Bite at the Apple
`The Kontos-based -00131 Petition is the third challenge Medtronic raises
`
`
`
`with respect to claims 25-39 of the ʼ380 patent. Medtronic also challenged claims
`
`25-39 of the ʼ380 patent on grounds based on Itou or, alternatively, Ressemann.
`
`IPR2020-00129, Paper 1 at 7-8. As a result, claims 25-39 of the ʼ380 patent
`
`4
`
`
`
`represent the only claim set for which Medtronic chose to present not just one, but
`
`two “back-up” grounds for the Itou reference—the -00131 petition is effectively a
`
`“back-up” for the “back-up.” Now, after the Board preliminarily rejected
`
`Medtronic’s first two arguments regarding claims 32 and 33, the Itou-based and
`
`Ressemann-based grounds (see IPR2020-00129, Paper 22 at 30-33), Medtronic
`
`wants to use its Kontos-based grounds for a third opportunity to challenge the same
`
`claims. This directly contravenes the principles of fairness and efficiency
`
`underlying the Board’s discretion in instituting multiple petitions. Medtronic’s
`
`offer to limit the challenged claims to claims 32 and 33 of the ʼ380 patent (see
`
`Paper 21 at 8) does nothing to alleviate this burden, as these claims are still subject
`
`to an entirely different legal and analytical framework than the claims in the -
`
`00127 and -00130 IPRs.
`
`II. Conclusion
`
`
`
`For the foregoing reasons, Teleflex respectfully requests that the Board deny
`
`Medtronic’s request for rehearing.
`
`5
`
`
`
`Dated: August 6, 2020.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/J. Derek Vandenburgh /
`J. Derek Vandenburgh (Lead Counsel)
`Registration No. 32,179
`Carlson, Caspers, Vandenburgh
` & Lindquist, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Telephone: (612) 436-9600
`Facsimile: (612) 436-9650
`Email:
`DVandenburgh@carlsoncaspers.com
`
`Lead Counsel for Patent Owner
`
`6
`
`
`
`CERTIFICATION OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e) and the agreement of the parties, the
`
`
`
`undersigned certifies that on August 6, 2020, a true and correct copy of the
`
`foregoing Patent Owner’s Response to Petitioners’ Request for Rehearing was
`
`served via electronic mail upon the following:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Cyrus A. Morton (Reg. No. 44,954)
`Sharon Roberg-Perez (Reg. No. 69,600)
`Christopher A. Pinahs (Reg. No. 76,375)
`Robins Kaplan LLP
`800 LaSalle Avenue, Suite 2800
`Minneapolis, MN 55401
`Phone: 349-8500
`Fax: 612-339-4181
`Email: Cmorton@robinskaplan.com
`Email: Sroberg-perez@robinskaplan.com
`Email: Cpinahs@robinskaplan.com
`
`
`
`
`
`
`
`
`
`/J. Derek Vandenburgh/
`J. Derek Vandenburgh (Lead Counsel for Patent Owner)
`
`
`
`
`7
`
`